RAP use from their announcement:
Potential customers ofResApp’s products include healthcare providers in telehealth, emergency department, urgent care and primary care settings as well as humanitarian organisations in the developing world.
RAP Study:
The Breathe Easy adult prospective study has completed recruitment, with 956 patients recruited.The study targeted diagnosis of lower respiratory tract disease, pneumonia, asthmaexacerbations and chronic obstructive pulmonary disease (COPD) exacerbations
If you want to know about asthma exacerbations, read:
https://www.healthline.com/health/asthma/acute-asthma-exacerbation
Now make up your own mind about what the RSH vs RAP (competition or not)
- Forums
- ASX - By Stock
- Ann: Shareholder teleconference presentation
RAP use from their announcement: Potential customers ofResApp’s...
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.6M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.8¢ | $5.307K | 68.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 140000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 52215 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 140000 | 0.077 |
1 | 34667 | 0.075 |
1 | 55392 | 0.074 |
1 | 1000000 | 0.072 |
3 | 1095422 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 52215 | 1 |
0.080 | 38873 | 1 |
0.081 | 56185 | 2 |
0.083 | 9677 | 1 |
0.084 | 115000 | 2 |
Last trade - 10.55am 01/11/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |